Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 60.84 · gapped below the open, then crossed back over prior close. High/low 61.81 at 4:00 pm ET, 58.59 at 10:45 am ET.
MBX Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
MBX (MBX Biosciences, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JEF −2.47%, in financials.
176 institutional managers report a position in MBX Biosciences, Inc. worth $3.1B between them, filed on form 13F for the quarter ending 2026-06-30. 20 of them hold 80% of it, the largest being Frazier Life Sciences Management, L.P. at 11.86%.
151 more managers in the register
20 managers hold 80% of the $3.1B institutional base. The other 156 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Frazier Life Sciences Management, L.P., NEA Management Company, LLC, Wellington Management Group LLP +6 more · 11.86% of MBX, 6.61% of TRVI
via NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Polar Capital Holdings Plc +5 more · 6.45% of MBX, 11.26% of SVRA
via Wellington Management Group LLP, Orbimed Advisors LLC, Deep Track Capital, LP +6 more · 8.88% of MBX, 10.83% of GPCR
via Frazier Life Sciences Management, L.P., Wellington Management Group LLP, Eventide Asset Management, LLC +6 more · 11.86% of MBX, 10.73% of MIRM
via Wellington Management Group LLP, Deep Track Capital, LP, Kynam Capital Management, LP +7 more · 8.88% of MBX, 11.13% of CLDX
via Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, Wellington Management Group LLP +4 more · 11.86% of MBX, 8.98% of ACHV
Managers holding a meaningful stake in MBX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.